Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
0.055 CAD 0.01 ( 10.00%)
Last update at 2026-11-04T16:43:00Z
VOLUME
49009
Market Cap
23.01M

Momentum Score

…

KDA Group Inc., together with its subsidiaries, provides technological and operational efficiency solutions for both the general and specialized health sectors in Canada. The company offers Adherize+, which is an intelligent patient engagement platform designed to monitor treatment adherence and provide tailored interventions; Medherize, a specialized module of Adherize+, focuses on patients undergoing complex therapies such as oral oncology treatments; KRx is an advanced electronic prescription platform for medical clinics; and CareMedic is digital health record and care coordination platform. The company was formerly known as AlliancePharma Inc. and changed its name to KDA Group Inc. in February 2017. KDA Group Inc. is headquartered in Thetford Mines, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.06
Low
0.06
High
52 Week Price Range
0.11
Low
0.42
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

KDA Group Inc (KDA.V) is a small-cap issuer on the TSX Venture with limited recent public disclosures about its core operations. Long-term growth appears to depend on successful execution of a clarified strategy such as asset development or acquisitions, which could support expansion if funded and managed effectively. Some investors may find potential upside from late-stage corporate developments but concrete, documented growth drivers are not publicly detailed.

The principal investment risk is limited transparency combined with thin trading liquidity, which increases execution, financing and valuation uncertainty.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.05
Dividend Yield
-
Revenue TTM
0.32M
Revenue Per Share
0.00
Gross Profit TTM
-2.89M
Debt / Equity
-
ROE
-88.20%
Net Debt
0.52M
ROCE
-95.77%
Diluted EPS TTM
-0.03

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-07-31 2024-07-31 2023-07-31 2022-07-31 2021-07-31
Type yearly yearly yearly yearly yearly
Date 2025-07-31 2024-07-31 2023-07-31 2022-07-31 2021-07-31
Income before tax -8.92M -7.60M 2.47M -4.65M 0.34M
Minority interest 0.88M 0.77M - 0.00M -0.00M
Net income -8.05M -6.91M 16.14M -4.56M 0.56M
Selling general administrative 6.05M 3.05M 3.11M 5.97M 5.07M
Gross profit -2.77M -1.29M 0.16M 8.06M 7.19M
Reconciled depreciation 3.06M 3.21M 0.57M 0.63M 0.48M
Ebit - - - 1.18M 1.43M
Ebitda - - - -0.54M 0.84M
Operating income -8.94M -4.63M -3.26M 1.46M 1.64M
Interest expense 0.09M 0.17M 1.39M 3.48M 0.01M
Tax provision 0.01M -0.15M 1.85M -0.08M -0.54M
Net interest income -0.09M -0.17M -1.39M -3.48M -3.12M
Income tax expense - - - -0.08M -0.54M
Total revenue 0.17M 0.15M 0.16M 28.82M 24.36M
Total operating expenses 9.11M 4.78M 3.42M 27.36M 22.72M
Cost of revenue 2.93M 1.43M 0.00M 20.76M 17.17M
Total other income expense net 0.12M -2.80M 7.12M -2.63M 1.83M
Discontinued operations - - - - -0.32M
Net income from continuing ops -8.93M -7.45M 0.62M -4.56M 0.89M
Net income applicable to common shares - - - -4.56M 0.56M
Breakdown 2025-07-31 2024-07-31 2023-07-31 2022-07-31 2021-07-31
Type yearly yearly yearly yearly yearly
Date 2025-07-31 2024-07-31 2023-07-31 2022-07-31 2021-07-31
Total assets 11.25M 13.39M 21.81M 28.67M 22.20M
Intangible assets 9.41M 11.07M 12.10M 10.16M 7.80M
Other current assets - - - - 0.23M
Total liab 2.04M 1.67M 5.31M 28.87M 18.29M
Total stockholder equity 10.87M 12.50M 16.51M -0.20M 3.91M
Deferred long term liab - - - 5.08M 2.44M
Other current liab - - - 1.78M 1.32M
Common stock - - - 29.90M 29.80M
Capital stock 36.09M 32.68M 30.26M 29.90M 29.80M
Retained earnings -31.79M -23.64M -16.84M -32.60M -28.04M
Other liab - - - 0.27M 0.34M
Good will 0.15M 0.15M 0.00M 6.31M 6.31M
Other assets - - - 7.49M 4.34M
Cash 0.13M 1.65M 4.63M 2.74M 1.72M
Total current liabilities 1.91M 0.82M 4.10M 22.44M 7.77M
Net debt 0.52M - - 10.07M 6.89M
Short long term debt 0.65M - 1.60M 8.22M 2.73M
Other stockholder equity - - - -0.37M 0.50M
Property plant equipment - - - 1.90M 0.34M
Total current assets 1.61M 2.05M 6.65M 7.88M 5.85M
Long term investments - 0.00M 1.20M - -
Net tangible assets - - - -11.60M -7.76M
Net receivables 0.03M 0.01M 0.46M 5.05M 3.75M
Long term debt - 0.68M - 4.59M 5.88M
Inventory - - - 0.00M 0.06M
Accounts payable 0.77M 0.44M 1.76M 2.70M 2.06M
Non current assets total 9.64M 11.34M 15.16M 20.79M 16.35M
Capital lease obligations 0.09M 0.13M 1.56M 1.85M 0.25M
Breakdown 2025-07-31 2024-07-31 2023-07-31 2022-07-31 2021-07-31
Type yearly yearly yearly yearly yearly
Date 2025-07-31 2024-07-31 2023-07-31 2022-07-31 2021-07-31
Investments 0.00M 0.88M 17.05M -2.68M -3.10M
Change to liabilities - - - 1.73M 1.34M
Total cashflows from investing activities - - - -2.68M -3.10M
Net borrowings 0.31M -1.05M - 2.26M -1.25M
Total cash from financing activities 2.21M 0.13M -14.31M 2.28M 0.09M
Change to operating activities - - - -0.39M -0.61M
Net income -8.05M -6.91M 16.14M -4.56M 0.56M
Change in cash -1.51M -2.99M 1.90M 1.02M -0.07M
Begin period cash flow 1.65M 4.63M 2.74M 1.72M 1.81M
End period cash flow 0.13M 1.65M 4.63M 2.74M 1.72M
Total cash from operating activities -2.36M -1.89M -0.84M 1.42M 2.94M
Issuance of capital stock 1.20M 1.12M - 0.00M 1.20M
Depreciation 3.06M 3.21M 0.57M 0.62M 0.48M
Other cashflows from investing activities - - - -0.05M -0.60M
Change to inventory - - 0.00M 0.00M 0.04M
Change to account receivables - 1.65M -2.19M -1.32M -0.06M
Sale purchase of stock - 0.00M -1.48M - -
Other cashflows from financing activities - - - - 0.13M
Change to netincome - - - 6.24M 1.16M
Capital expenditures 1.36M 2.10M 2.13M 0.05M 0.05M
Change in working capital 0.35M 0.49M -2.70M -0.88M 0.74M
Stock based compensation 3.12M 0.38M 0.21M 0.28M 0.88M
Other non cash items 0.04M 1.26M -9.56M 2.90M -3.99M
Free cash flow -3.73M -3.99M -2.98M -1.21M 0.44M

Peer Comparison*

Sector: Healthcare Industry: Medical Care Facilities

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
KDA
KDA Group Inc
0.01
10.00%
0.06 - - 72.57 2.93 85.92 23.03
NPTH
NeuPath Health Inc
0.01
1.85%
0.55 - 7.75 0.39 1.69 0.50 13.93
NLH
Nova Leap Health Corp
-0.01
2.08%
0.47 - 20.49 1.08 1.30 0.83 24.88
JNH
Jack Nathan Medical Corp
-
-%
0.01 - - 0.25 7.84 0.64 -1.92
ELM
Element Lifestyle Retirement Inc
-
-%
0.01 - - 0.63 174.48 2.12 11.33

Profile*

KDA Group Inc

KDA Group Inc., together with its subsidiaries, provides technological and operational efficiency solutions for both the general and specialized health sectors in Canada. The company offers Adherize+, which is an intelligent patient engagement platform designed to monitor treatment adherence and provide tailored interventions; Medherize, a specialized module of Adherize+, focuses on patients undergoing complex therapies such as oral oncology treatments; KRx is an advanced electronic prescription platform for medical clinics; and CareMedic is digital health record and care coordination platform. The company was formerly known as AlliancePharma Inc. and changed its name to KDA Group Inc. in February 2017. KDA Group Inc. is headquartered in Thetford Mines, Canada.

1351, Notre Dame St. East, Thetford Mines, QC, Canada, G6G 0G5

418 755 0821

Name Title Year Born
Mr. Marc Lemieux Co-Founder, Chairman, CEO & Pres NA
Ms. Isabelle Begin Co-Founder, Exec. VP of Pharmacy Services Division & Director NA
Mr. Jean-Pierre Robert B.Sc. Chief Operating Officer NA
Mr. Pierre Monet Sec. NA
Mr. Luc Olivier Chief Financial Officer NA
Dr. Giuseppe D'Aprano Chief Scientific Officer NA
Ms. Annie Mercier Controller NA
Mr. Jean-Marc Leveille Member of Strategic Advisory Board and Consultant of HR & Strategic Planning NA
Mr. Marc Lemieux Co-Founder, Chairman, CEO & President NA
Ms. Isabelle Begin Co-Founder & Director NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…